Dr Reddys receives EIR from USFDA for API facility at Srikakulam

Image
Capital Market
Last Updated : May 08 2020 | 9:32 AM IST

Don't want to miss the best from Business Standard?

Dr Reddys Laboratories has received the Establishment Inspection Report (EIR) from US FDA, for its API manufacturing plant at Srikakulam, Andhra Pradesh (CTO VI) indicating closure of the audit and the inspection classification of this facility is determined as "Voluntary Action Indicated" (VAI).

It may be noted that the site was issued warning letter in November, 2015 after the inspection in 2014, and was under "Official Action Indicated" classification till now.

With this, all facilities under warning letter are now determined as VAI.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: May 08 2020 | 9:16 AM IST

Next Story